C1q as a target molecule to treat human disease: What do mouse studies teach us?

Overview of attention for article published in Frontiers in immunology, August 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?

Article in Journal of Neuroimmunology (August 2024)

The Depth of the Molecular Response in Patients with Chronic Myeloid Leukemia Correlates with Changes in Humoral Immunity

Article in Journal of Clinical Medicine (April 2024)

Crystal structure of Trichinella spiralis calreticulin and the structural basis of its complement evasion mechanism involving C1q

Article in Frontiers in Immunology (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.